Literature DB >> 23351

Drug refusal in schizophrenia: causes and prescribing hints.

T Van Putten.   

Abstract

Many discharged patients diagnosed as schizophrenic do not continue to take their prescribed antipsychotic medication. Reasons for reluctance to take drugs include the development of extrapyramidal symptoms, most notably akathisia and akinesia; a poor doctor-patient relationship; or the patient's preference to continue his schizophrenic existence. To improve drug compliance, the physician should ask the patient about his impressions of side-effects and should let the patient help determine the optimal dosage.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 23351     DOI: 10.1176/ps.29.2.110

Source DB:  PubMed          Journal:  Hosp Community Psychiatry        ISSN: 0022-1597


  7 in total

Review 1.  The primary care of patients with schizophrenia: a search for good practice.

Authors:  T Burns; T Kendrick
Journal:  Br J Gen Pract       Date:  1997-08       Impact factor: 5.386

2.  Intranasal drug delivery of olanzapine-loaded chitosan nanoparticles.

Authors:  Sarah Baltzley; Atiquzzaman Mohammad; Ahmad H Malkawi; Abeer M Al-Ghananeem
Journal:  AAPS PharmSciTech       Date:  2014-08-21       Impact factor: 3.246

3.  The clinical phenomenon of akathisia.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-08       Impact factor: 10.154

4.  Cost-benefit analysis of risperidone and clozapine in the treatment of schizophrenia in Israel.

Authors:  G Ginsberg; S Shani; B Lev
Journal:  Pharmacoeconomics       Date:  1998-02       Impact factor: 4.981

5.  Coarse, jerky foot tremor: tremographic investigation of an objective sign of acute akathisia.

Authors:  W M Braude; I P Charles; T R Barnes
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

Review 6.  The problem of non-compliance with drug therapy.

Authors:  L Evans; M Spelman
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546

7.  Medication adherence in schizophrenia: patient perspectives and the clinical utility of paliperidone ER.

Authors:  Michael Birnbaum; Zafar Sharif
Journal:  Patient Prefer Adherence       Date:  2008-02-02       Impact factor: 2.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.